返回 Agendas
Social Media: Opportunities and Challenges in Pharmacovigilance and Clinical Research
Session Chair(s)
Martin Harvey Allchurch, LLM
Head of International Affairs
European Medicines Agency, Netherlands
This session will discuss the potential of social media as a new data source in the early detection of safety issues related to medicines. Social media usage has increased substantially within the last five years, including the creation, sharing or exchange of information on health-related topics and has already shown promise in the management of disease outbreaks, for example. Therefore, the expectation is that the use of data from a real-world, large-scale population of consumers and patients will result in more comprehensive and timely information about the safe use of medicines. However, this new data source also brings a number of challenges such as compliance with data privacy requirements, ethical aspects or risks in compromising clinical research results, which will be further outlined. Lessons learned from MedWatcher Social as well as the approach towards social media analytics currently being researched in the context of the Innovative Medicines Initiative (IMI) WEB-Recognising Adverse Drug Reactions (RADR) project will be discussed.
Learning Objective : Discuss social media analytics for the purpose of detecting new safety issues and medical insights in relation to medicines based on MedWatcher Social platform; Describe the impact of the use of social media by clinical study participants on clinical research; Discuss the WEB-Recognising Adverse Drug Reactions (RADR) project; Describe data privacy implications and ethical and societal aspects in relation to the use of social media analytics for the purpose of pharmacovigilance.
Speaker(s)
Social Media: Impact on Clinical Studies
Alexis Reisin Miller, JD
Merck & Co., Inc., United States
Head, Global Regulatory Policy
Digital Drug Safety
Carrie E. Pierce, MBA, MPH
Epidemico, United States
Senior Project Manager
Social Media Analytics
Martin Harvey Allchurch, LLM
European Medicines Agency, Netherlands
Head of International Affairs